GB0214784D0 - Novel combination - Google Patents
Novel combinationInfo
- Publication number
- GB0214784D0 GB0214784D0 GBGB0214784.1A GB0214784A GB0214784D0 GB 0214784 D0 GB0214784 D0 GB 0214784D0 GB 0214784 A GB0214784 A GB 0214784A GB 0214784 D0 GB0214784 D0 GB 0214784D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel combination
- novel
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Reproductive Health (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (21)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0214784.1A GB0214784D0 (en) | 2002-06-26 | 2002-06-26 | Novel combination |
GT200300124A GT200300124A (en) | 2002-06-26 | 2003-06-04 | NEW COMBINATION |
PA20038575501A PA8575501A1 (en) | 2002-06-26 | 2003-06-13 | NEW COMBINATION |
PCT/IB2003/002657 WO2004002461A2 (en) | 2002-06-26 | 2003-06-16 | Combination of pde5 inhibitors with angiotensin ii receptor antagonists |
EP03761725A EP1524996A2 (en) | 2002-06-26 | 2003-06-16 | Combination of pde5 inhibitors with angiotensin ii receptor antagonists |
CA002491002A CA2491002A1 (en) | 2002-06-26 | 2003-06-16 | Combination of pde5 inhibitors with angiotensin ii receptor antagonists |
CN03814574XA CN1662257A (en) | 2002-06-26 | 2003-06-16 | Combination of PDE5 inhibitors with angiotensin II receptor antagonists |
BR0312030-9A BR0312030A (en) | 2002-06-26 | 2003-06-16 | Combination of pde5 inhibitors with angiotensin ii receptor antagonists |
RU2004136276/15A RU2004136276A (en) | 2002-06-26 | 2003-06-16 | COMBINATION OF PDE5 INHIBITORS WITH ANGIOTENSIN RECEPTOR ANTAGONISTS 11 |
JP2004517093A JP2005531627A (en) | 2002-06-26 | 2003-06-16 | New mixed medicine |
KR10-2004-7021041A KR20050013156A (en) | 2002-06-26 | 2003-06-16 | Novel Combination |
MXPA04012569A MXPA04012569A (en) | 2002-06-26 | 2003-06-16 | Combination of pde5 inhibitors with angiotensin ii receptor antagonists. |
PL03375079A PL375079A1 (en) | 2002-06-26 | 2003-06-16 | Novel combination |
AU2003242895A AU2003242895A1 (en) | 2002-06-26 | 2003-06-16 | Combination of PDE5 inhibitors with angiotensin II receptor antagonists |
TW092116851A TW200404546A (en) | 2002-06-26 | 2003-06-20 | Novel combination |
PE2003000636A PE20040868A1 (en) | 2002-06-26 | 2003-06-24 | NEW COMBINATION OF TYPE 5 PHOSPHODIESTERASE INHIBITOR (PDE5) AND ANGIOTENSIN II RECEPTOR ANTAGONIST |
ARP030102252A AR040337A1 (en) | 2002-06-26 | 2003-06-24 | USE OF A COMBINATION OF A TYPE 5 (PDE5) PHOSPHODIESTERASE INHIBITOR SPECIFY OF CYCLIC GUANOSINE MONOPHOSPHATE (GMPC) AND AN ANGIOTENSIN II RECEIVER ANTAGONIST TO PREPARE A MEDICINAL PRODUCT |
UY27863A UY27863A1 (en) | 2002-06-26 | 2003-06-24 | NEW COMBINATION |
US10/603,369 US20040132731A1 (en) | 2002-06-26 | 2003-06-25 | Novel combination |
ZA200409532A ZA200409532B (en) | 2002-06-26 | 2004-11-25 | Novel combination |
NO20050400A NO20050400L (en) | 2002-06-26 | 2005-01-25 | New combination preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0214784.1A GB0214784D0 (en) | 2002-06-26 | 2002-06-26 | Novel combination |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0214784D0 true GB0214784D0 (en) | 2002-08-07 |
Family
ID=9939342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0214784.1A Ceased GB0214784D0 (en) | 2002-06-26 | 2002-06-26 | Novel combination |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1524996A2 (en) |
JP (1) | JP2005531627A (en) |
KR (1) | KR20050013156A (en) |
CN (1) | CN1662257A (en) |
AR (1) | AR040337A1 (en) |
AU (1) | AU2003242895A1 (en) |
BR (1) | BR0312030A (en) |
CA (1) | CA2491002A1 (en) |
GB (1) | GB0214784D0 (en) |
GT (1) | GT200300124A (en) |
MX (1) | MXPA04012569A (en) |
NO (1) | NO20050400L (en) |
PA (1) | PA8575501A1 (en) |
PE (1) | PE20040868A1 (en) |
PL (1) | PL375079A1 (en) |
RU (1) | RU2004136276A (en) |
TW (1) | TW200404546A (en) |
UY (1) | UY27863A1 (en) |
WO (1) | WO2004002461A2 (en) |
ZA (1) | ZA200409532B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7019010B2 (en) | 2001-09-27 | 2006-03-28 | Novertis Ag | Combinations |
KR100722897B1 (en) * | 2002-07-26 | 2007-05-31 | 올림푸스 가부시키가이샤 | Image processing system |
US20060205733A1 (en) * | 2004-08-26 | 2006-09-14 | Encysive Pharmaceuticals | Endothelin a receptor antagonists in combination with phosphodiesterase 5 inhibitors and uses thereof |
BRPI0502411A (en) * | 2005-03-31 | 2006-11-28 | Univ Minas Gerais | process of developing substances as potent and selective inhibitors of phosphodiesterase isoforms of types 1 to 5 (pde1, pde2, pde3, pde4, pde5) based on diocleine, fluranol or analogs and their pharmaceutical compositions for the study and treatment of cardiovascular disease and associated products |
DK1888074T3 (en) | 2005-06-10 | 2012-01-23 | Dong A Pharm Co Ltd | Agent for the prevention and treatment of liver diseases containing pyrazolopyrimidine derivative |
EP1909793A2 (en) * | 2005-07-15 | 2008-04-16 | Proxomed Medizintechnik GmbH | Use of phosphodiesterase type 5 inhibitors for the prevention and treatment of diseases or health disorders and dispensing system for said inhibitors |
EP1940389A2 (en) * | 2005-10-21 | 2008-07-09 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
EP2377531A2 (en) * | 2006-05-09 | 2011-10-19 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
US7858611B2 (en) | 2006-05-09 | 2010-12-28 | Braincells Inc. | Neurogenesis by modulating angiotensin |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9013750D0 (en) * | 1990-06-20 | 1990-08-08 | Pfizer Ltd | Therapeutic agents |
GB9401090D0 (en) * | 1994-01-21 | 1994-03-16 | Glaxo Lab Sa | Chemical compounds |
ATE213246T1 (en) * | 1997-11-12 | 2002-02-15 | 2-PHENYL-SUBSTITUTED IMIDAZOTRIAZINONES AS PHOSPHODIESTERASE INHIBITORS | |
DZ3218A1 (en) * | 1999-10-11 | 2001-04-19 | Pfizer | PYRIMIDINE-7-ONES 5- (2-SUBSTITUTEES-5-HETEROCYCLYLSULPHONYLPYRIDE-3-YL) -DIHYDROPYRAZOLO [4,3-D] AS PHOSPHODIESTERASE INHIBITORS |
TWI265925B (en) * | 1999-10-11 | 2006-11-11 | Pfizer | Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them |
JP2004506009A (en) * | 2000-08-11 | 2004-02-26 | ファイザー・インク | Treatment of insulin resistance syndrome |
-
2002
- 2002-06-26 GB GBGB0214784.1A patent/GB0214784D0/en not_active Ceased
-
2003
- 2003-06-04 GT GT200300124A patent/GT200300124A/en unknown
- 2003-06-13 PA PA20038575501A patent/PA8575501A1/en unknown
- 2003-06-16 PL PL03375079A patent/PL375079A1/en not_active Application Discontinuation
- 2003-06-16 KR KR10-2004-7021041A patent/KR20050013156A/en not_active Application Discontinuation
- 2003-06-16 MX MXPA04012569A patent/MXPA04012569A/en unknown
- 2003-06-16 CA CA002491002A patent/CA2491002A1/en not_active Abandoned
- 2003-06-16 JP JP2004517093A patent/JP2005531627A/en not_active Withdrawn
- 2003-06-16 RU RU2004136276/15A patent/RU2004136276A/en not_active Application Discontinuation
- 2003-06-16 EP EP03761725A patent/EP1524996A2/en not_active Withdrawn
- 2003-06-16 AU AU2003242895A patent/AU2003242895A1/en not_active Abandoned
- 2003-06-16 CN CN03814574XA patent/CN1662257A/en active Pending
- 2003-06-16 WO PCT/IB2003/002657 patent/WO2004002461A2/en not_active Application Discontinuation
- 2003-06-16 BR BR0312030-9A patent/BR0312030A/en not_active IP Right Cessation
- 2003-06-20 TW TW092116851A patent/TW200404546A/en unknown
- 2003-06-24 PE PE2003000636A patent/PE20040868A1/en not_active Application Discontinuation
- 2003-06-24 UY UY27863A patent/UY27863A1/en not_active Application Discontinuation
- 2003-06-24 AR ARP030102252A patent/AR040337A1/en not_active Application Discontinuation
-
2004
- 2004-11-25 ZA ZA200409532A patent/ZA200409532B/en unknown
-
2005
- 2005-01-25 NO NO20050400A patent/NO20050400L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
GT200300124A (en) | 2004-03-17 |
AU2003242895A1 (en) | 2004-01-19 |
WO2004002461A3 (en) | 2004-05-13 |
MXPA04012569A (en) | 2005-04-19 |
BR0312030A (en) | 2005-03-22 |
CN1662257A (en) | 2005-08-31 |
PA8575501A1 (en) | 2003-12-30 |
ZA200409532B (en) | 2006-06-28 |
AR040337A1 (en) | 2005-03-30 |
KR20050013156A (en) | 2005-02-02 |
UY27863A1 (en) | 2003-12-31 |
RU2004136276A (en) | 2005-09-10 |
PL375079A1 (en) | 2005-11-14 |
CA2491002A1 (en) | 2004-01-08 |
PE20040868A1 (en) | 2004-11-25 |
NO20050400L (en) | 2005-03-29 |
WO2004002461A2 (en) | 2004-01-08 |
JP2005531627A (en) | 2005-10-20 |
TW200404546A (en) | 2004-04-01 |
EP1524996A2 (en) | 2005-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL166084A0 (en) | Novel benzodioxoles | |
PL371678A1 (en) | Novel pyridin- and pyrimidin-derivatives | |
PL373598A1 (en) | Novel benzonaphthyridines | |
AU2003249738A8 (en) | Ostoscope | |
AU2003297193A8 (en) | Meta-web | |
DE50309217D1 (en) | Benzimidazolderivate | |
AU2003252028A8 (en) | Heterodiamondoids | |
IL163529A0 (en) | Novel spinosyn-producing polyketidesynthases | |
AU2003279495A8 (en) | Alert-modeling | |
DE50308027D1 (en) | Cyclohexyl-harnstoff-derivate | |
DE50303619D1 (en) | Reibschweissvorrichtung | |
DE50307787D1 (en) | Isophthalsäurederivate | |
IL164975A0 (en) | Novel combination | |
GB0214784D0 (en) | Novel combination | |
AU2002367810A8 (en) | Bis-transition-metal-chelate-probes | |
AU2003264900A8 (en) | Cast-cutter | |
DE50304964D1 (en) | Handhobelmaschine | |
GB0225873D0 (en) | Combination | |
AU2003262681A8 (en) | Hemo-aide | |
DE10392833D2 (en) | Geotextilie | |
AU2002341221A8 (en) | Honey-brandy | |
DE50309021D1 (en) | Etherlacton | |
GB0229743D0 (en) | Novel benzoxazocines | |
GB0225874D0 (en) | Combination | |
GB0225875D0 (en) | Combination |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |